Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment
18 Jan 2021 - IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3
23 Nov 2020 - IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations
24 Sep 2020 - UK Earnings, Trading Statements Calendar - Next 7 Days
17 Sep 2020 - Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production
18 Aug 2020 - IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product
15 Jun 2020 - Faron Pharmaceuticals gets Finnish state loan for manufacturing process
15 Jun 2020 - Faron receives EIC grant for 'MATINS' study
11 Jun 2020
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment
Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment
IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3
IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3
IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations
IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production
Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production
IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product
IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product
Faron Pharmaceuticals gets Finnish state loan for manufacturing process
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced plans to initiate a new "state-of-the-art" process for the...
Faron receives EIC grant for 'MATINS' study
(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has been selected to receive a €2.5m (£2.24m) grant from ...
Follow the stocks
